Clinical Research Directory
Browse clinical research sites, groups, and studies.
Corticosteroids to Treat Pancreatitis
Sponsor: Beth Israel Deaconess Medical Center
Summary
This research is being done to determine if the administration of a short course of intravenous hydrocortisone, an anti-inflammatory medication, to patients with severe acute pancreatitis will improve their clinical outcomes and decrease the length of hospitalization. We think that because inflammation in the body drives the progression of pancreatitis, giving a short course of intravenous hydrocortisone may mitigate disease progression and improve clinical outcomes in patients with severe acute pancreatitis.
Official title: Corticosteroids to Reduce Inflammation in Severe Pancreatitis: A Randomized, Controlled Study
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2022-03-06
Completion Date
2027-04
Last Updated
2026-02-18
Healthy Volunteers
No
Interventions
Hydrocortisone
Hydrocortisone is a steroid (corticosteroid) medication.
Placebo
50ml of 0.9% NACL will serve as the placebo
Locations (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States